Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,326–6,350 of 7,816 matching trials · page 254 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Apathy Associated With Alzheimer's Disease NCT00254033 Dextroamphetamine; Methylphenidate Runs in: Canada · 1 site |
PHASE4 other |
COMPLETED | 40 | Sunnybrook Health Sciences Centre OTHER |
2017-04-28 |
|
Study to Evaluate Coconut Oil for Alzheimer's Disease NCT01883648 Coconut Oil Beverage; Placebo Beverage Runs in: United States · 1 site |
PHASE2|PHASE3 other |
TERMINATED | 21 | University of South Florida OTHER |
2017-04-28 |
|
Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease NCT02035982 Cholinesterase Inhibitor; Placebo Runs in: Canada · 2 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | 40 | Sunnybrook Health Sciences Centre OTHER |
2017-04-28 |
|
Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia NCT00315900 Depakote ER; Seroquel Runs in: United States · 1 site |
PHASE3 other |
TERMINATED | 20 | Tuscaloosa Research & Education Advancement Corporation OTHER |
2017-04-27 |
|
Alzheimers Disease and Neuromarkers in Patients With Acute Hip Fractures NCT02409082 Runs in: Sweden · 1 site |
NA other |
COMPLETED | 400 | Sahlgrenska University Hospital OTHER |
2017-04-26 |
|
Washing Without Water: Cost-effectiveness of a Rapidly Spreading Nursing Intervention in Bedridden Patients' NCT01187732 Washing without water Runs in: Netherlands · 1 site |
NA other |
COMPLETED | 500 | Betsie van Gaal OTHER |
2017-04-25 |
|
Pharmacokinetic Study Comparing Topical, Rectal, and Oral Quetiapine NCT02131545 Quetiapine 25 mg gel applied topically; Quetiapine 25 mg tablet by ... Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 10 | Mayo Clinic OTHER |
2017-04-25 |
|
Comparison of Ketamine-propofol Combinations NCT02848963 Ketamine-propofol mixture Runs in: Turkey (Türkiye) · 1 site |
PHASE4 other |
COMPLETED | 75 | Cukurova University OTHER |
2017-04-20 |
|
Optimisation of Antipsychotic Drug Use in Older People NCT01454453 Patients- dose titration Runs in: United Kingdom · 1 site |
PHASE4 other |
TERMINATED | 64 | Institute of Psychiatry, London OTHER |
2017-04-19 |
|
Dementia Patient's Behavior Evaluation Using Noninvasive Ambient Sensor NCT03120741 Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 35 | National Taiwan University Hospital OTHER |
2017-04-19 |
|
Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET) NCT01607476 C11 PiB; F18 Flutametamol Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 89 | Mayo Clinic OTHER |
2017-04-18 |
|
Beta Testing of a New Assessment in Huntington's Disease (HD) NCT03119246 CAPIT-HD beta Runs in: France · 1 site |
NA other |
UNKNOWN | 40 | Assistance Publique - Hôpitaux de Paris OTHER |
2017-04-18 |
|
Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women NCT00611533 atomoxetine; placebo Runs in: United States · 1 site |
NA other |
COMPLETED | 16 | University of Pennsylvania OTHER |
2017-04-17 |
|
The Primary Care - Dementia Assessment and Treatment Algorithm NCT01548053 PC-DATA tool Runs in: Canada · 1 site |
NA other |
COMPLETED | 55 | Queen's University OTHER |
2017-04-14 |
|
Volunteers Adding Life in Dementia NCT01646723 Volunteers Adding Life in Dementia (VALID) Program Runs in: Canada · 1 site |
NA other |
COMPLETED | 75 | Queen's University OTHER |
2017-04-14 |
|
Volunteers Adding Life in Dementia: VALID NCT01715181 Volunteer visits Runs in: Canada · 1 site |
NA other |
COMPLETED | 75 | Queen's University OTHER |
2017-04-14 |
|
Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease? A Validation Study Using PET With Florbetapir (AV-45). NCT01746706 PET amyloid tracer (Florbetapir F18 AV45 F18 Runs in: France · 1 site |
NA other |
UNKNOWN | 80 | Assistance Publique Hopitaux De Marseille OTHER |
2017-04-14 |
|
Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients NCT03113812 ABvac40; Placebo |
PHASE1 other |
COMPLETED | 24 | Araclon Biotech S.L. INDUSTRY |
2017-04-14 |
|
Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease NCT01009255 GSK239512; Placebo Runs in: Bulgaria; Chile; Czechia; Germany; Russia; Slovakia; Sout... · 35 sites |
PHASE2 other |
COMPLETED | 196 | GlaxoSmithKline INDUSTRY |
2017-04-13 |
|
Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease NCT01058941 Lipoic acid and fish oil concentrate; Placebo Runs in: United States · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 67 | Oregon Health and Science University OTHER |
2017-04-13 |
|
Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease NCT02360527 Runs in: Spain · 1 site |
NA other |
COMPLETED | 126 | Hospital Universitari Vall d'Hebron Research Institute OTHER |
2017-04-12 |
|
Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease NCT02501876 There is a retrospectiv observational study. No intervention Runs in: Spain · 1 site |
NA other |
COMPLETED | 202 | Hospital Universitari Vall d'Hebron Research Institute OTHER |
2017-04-12 |
|
Depression in Alzheimer's Disease-2 NCT00086138 Sertraline (Zoloft); Placebo Runs in: United States · 5 sites |
PHASE2|PHASE3 other |
COMPLETED | 131 | Johns Hopkins University OTHER |
2017-04-11 |
|
Treating Cancer-Related Fatigue Through Systematic Light Exposure NCT01873794 Bright white light; Dim red light Runs in: United States · 2 sites |
NA other |
COMPLETED | 54 | Icahn School of Medicine at Mount Sinai OTHER |
2017-04-11 |
|
Hearing Instruments in Alzheimer's Disease NCT02294513 Standard audiologic rehabilitation (incl. HI) Runs in: Canada · 1 site |
NA other |
COMPLETED | 25 | Phonak AG, Switzerland INDUSTRY |
2017-04-11 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial